Navigation Links
Smith & Nephew CEO Interviewed on Q2 2011 Results
Date:8/5/2011

LONDON, August 5, 2011 /PRNewswire/ --

 

Medical devices group Smith & Nephew reports sales growth of 12% and underlying sales growth of 5%.

In an interview with financial broadcaster http://www.cantos.com, new CEO Olivier Bohuon talks Q2 results and introduces his plans for a new Strategic Framework that details efficiency plans and announces a new focus on emerging markets. 

Bohuon also announced plans to inject an additional $300m into R&D over the next five years, and to focus the business on performance, innovation and a more global presence.

The interview and transcript are available now on http://www.cantos.com/company/Smith%20and%20Nephew

Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email prnsupport@cantos.com or phone +44-207-936-1352.


'/>"/>
SOURCE Smith & Nephew plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment
2. Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline
3. Canadas Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing
4. GlaxoSmithKline and Amplimmune Form Global Strategic Collaboration
5. Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee
6. Academics Launch New Web Site Holding Jeffrey Smith's Claims on GM Foods Up to Peer-Reviewed Science
7. SpineSmith to Present at the 5th Annual Stem Cell Summit
8. SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement
9. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
10. FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKlines Candidate Cervical Cancer Vaccine
11. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... - FACIT announced a seed stage investment in ... created by FACIT focused on developing a portfolio ... non-dilutive capital, achieves a targeted $3.0M financing for ... to accelerate the nomination of a candidate drug ... a strategic partnership for clinical trials in patients ...
(Date:3/22/2017)... March 22, 2017   VWR ... of product and service solutions to laboratory ... has acquired EPL Archives, Inc., an international ... the entire regulated product research, development and ... storage and ancillary services. EPL Archives is ...
(Date:3/22/2017)... (PRWEB) , ... March 21, 2017 , ... Okyanos Cell ... seminar as part of their live events series, “Stem Cell Therapy: The Next Phase ... facility under the 2013 Stem Cell Research and Therapy Act, Okyanos maintains ...
(Date:3/22/2017)... ... , ... Benchworks CEO Thad L. Bench Sr. will participate in ... in San Diego. The event is a gathering of executive leadership from companies in ... Christian Meyer will also participate in the forum. Participants will discuss the future of ...
Breaking Biology Technology:
(Date:2/24/2017)... Feb. 24, 2017  EyeLock LLC, a leader of iris-based ... iris biometric solution on the latest Qualcomm® Snapdragon™ ... Mobile World Congress 2017 (February 27 – ... Hall 3, Stand 3E10. The ... security platform—a combination of hardware, software and ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):